Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience.

J Asthma

School of Medicine, University of Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland.

Published: May 2020

Download full-text PDF

Source
http://dx.doi.org/10.1080/02770903.2019.1579833DOI Listing

Publication Analysis

Top Keywords

mepolizumab adolescents
4
adolescents severe
4
severe eosinophilic
4
eosinophilic asthma
4
asthma eligible
4
eligible omalizumab
4
omalizumab center's
4
center's early
4
early clinical
4
clinical experience
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!